Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GW-5823: CCK-A agonist for treatment of obesity

Aug. 16, 1996

ImmuCell, Agri-Mark establish lactoferrin JV

Aug. 16, 1996

Hypolipidemic agents described by Bayer

Aug. 16, 1996

RPR reports squalene synthase inhibitors

Aug. 16, 1996

Takeda claims benzothiepin derivatives to treat bone disease

Aug. 16, 1996

9-cis-retinoids as heart disease therapy described by American Cyanamid

Aug. 9, 1996

Columbia seeks FDA approval of Crinone

Aug. 9, 1996

Aldose reductase inhibitors disclosed by Nippon Zoki

Aug. 9, 1996

FDA approves phaseI/II trial of VivoRx's BetaRx-P

Aug. 9, 1996

FDA approves expanded date labelling for LeukoNet

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...